Update on botulinum toxin and dermal fillers

被引:12
作者
Berbos, Zachary J. [2 ]
Lipham, William J. [1 ,2 ]
机构
[1] Minnesota Eye Consultants PA, Bloomington, MN 55416 USA
[2] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA
关键词
botulinum toxin; dermal fillers; facial rejuvenation; HYALURONIC-ACID FILLERS; NEUROTOXIN SEROTYPE-A; DOUBLE-BLIND; GLABELLAR LINES; FACIAL REJUVENATION; COMPLEXING PROTEINS; COMBINATION THERAPY; PARALLEL-GROUP; FORMULATIONS; BTX-A;
D O I
10.1097/ICU.0b013e32833ce7bc
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose of review The art and science of facial rejuvenation is an ever-evolving field of medicine, as evidenced by the continual development of new surgical and nonsurgical treatment modalities. Over the past 10 years, the use of botulinum toxin and dermal fillers for aesthetic purposes has risen sharply. Herein, we discuss properties of several commonly used injectable products and provide basic instruction for their use toward the goal of achieving facial rejuvenation. Recent findings The demand for nonsurgical injection-based facial rejuvenation products has risen enormously in recent years. Used independently or concurrently, botulinum toxin and dermal filler agents offer an affordable, minimally invasive approach to facial rejuvenation. Summary Botulinum toxin and dermal fillers can be used to diminish facial rhytides, restore facial volume, and sculpt facial contours, thereby achieving an aesthetically pleasing, youthful facial appearance.
引用
收藏
页码:387 / 395
页数:9
相关论文
共 70 条
[11]   Botulinum toxin type B (Myobloc®):: Pharmacology and biochemistry [J].
Callaway, JE .
CLINICS IN DERMATOLOGY, 2004, 22 (01) :23-28
[12]   Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids [J].
Carruthers, A ;
Carruthers, J .
DERMATOLOGIC SURGERY, 2005, 31 (10) :1297-1303
[13]  
Carruthers A, 2008, Skin Therapy Lett, V13, P1
[14]   Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: Does it matter? [J].
Carruthers, Alastair ;
Carruthers, Jean ;
Cohen, Joel .
DERMATOLOGIC SURGERY, 2007, 33 :S97-S104
[15]   A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: Treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A [J].
Carruthers, J ;
Carruthers, A .
DERMATOLOGIC SURGERY, 2003, 29 (08) :802-809
[16]   Deep resting glabellar rhytides respond to BTX-A and Hylan B [J].
Carruthers, J ;
Carruthers, A ;
Maberley, D .
DERMATOLOGIC SURGERY, 2003, 29 (05) :539-544
[17]  
Carruthers Jean, 2007, Facial Plast Surg Clin North Am, V15, P51, DOI 10.1016/j.fsc.2006.10.004
[18]   Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations [J].
Carruthers, Jean D. A. ;
Glogau, Richard G. ;
Blitzer, Andrew .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 121 (05) :5S-30S
[19]   Botulinum neurotoxin serotype A: A clinical update on non-cosmetic uses [J].
Charles, PD .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (22) :S11-S23
[20]  
Cliff Sandeep H, 2008, J Cosmet Dermatol, V7, P50, DOI 10.1111/j.1473-2165.2008.00361.x